Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

New research shows that most people regain weight after stopping Ozempic and similar weight-loss drugs around the eight-week ...

Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to ...

Some 20 weeks after stopping their drugs, the participants in the studies had put back on an average of 2.5 kilograms (5.5 ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

Mini meals with bite size portions are meant to appeal to people taking GLP-1 weight-loss drugs that reduce appetite.

Most of the scariest side effects of weight-loss drugs like Ozempic, Wegovy, and Zepbound have been gastrointestinal. Patients using these injectable GLP-1 medications have shared horror stories about ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there? Here's what to know.